These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9818299)
1. Lack of effects of the Na+/H+ exchanger inhibitor, cariporide against myocardial stunning in exercise-induced ischemia in dogs. Parent de Curzon O; Ghaleh B; Giudicelli JF; Berdeaux A Fundam Clin Pharmacol; 1998; 12(6):646-8. PubMed ID: 9818299 [No Abstract] [Full Text] [Related]
2. The role of sodium-hydrogen ion exchange in patients undergoing coronary artery bypass grafting. Bolli R J Card Surg; 2003; 18 Suppl 1():21-6. PubMed ID: 12691376 [TBL] [Abstract][Full Text] [Related]
4. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Avkiran M Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175 [TBL] [Abstract][Full Text] [Related]
5. Development of the Na+/H+ exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial. Scholz W; Jessel A; Albus U J Thromb Thrombolysis; 1999 Jul; 8(1):61-70. PubMed ID: 10481216 [No Abstract] [Full Text] [Related]
14. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Théroux P; Chaitman BR; Danchin N; Erhardt L; Meinertz T; Schroeder JS; Tognoni G; White HD; Willerson JT; Jessel A Circulation; 2000 Dec; 102(25):3032-8. PubMed ID: 11120691 [TBL] [Abstract][Full Text] [Related]
15. Myocardial stunning following no flow ischaemia is diminished by levosimendan or cariporide, without benefits of combined administration. Brendt P; Behrends M; Peters J Resuscitation; 2008 Jan; 76(1):95-102. PubMed ID: 17719165 [TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of na(+)/h(+)-exchanger in the heart. Baartscheer A Curr Vasc Pharmacol; 2006 Jan; 4(1):23-9. PubMed ID: 16472174 [TBL] [Abstract][Full Text] [Related]
17. Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals. Menown IB; Adgey AA J Am Coll Cardiol; 2001 Nov; 38(6):1651-3. PubMed ID: 11704376 [No Abstract] [Full Text] [Related]
18. Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion. Buerke M; Rupprecht HJ; vom Dahl J; Terres W; Seyfarth M; Schultheiss HP; Richardt G; Sheehan FH; Drexler H Am J Cardiol; 1999 May; 83(10A):19G-22G. PubMed ID: 10482176 [TBL] [Abstract][Full Text] [Related]
19. GUARD During Ischemia Against Necrosis (GUARDIAN) trial in acute coronary syndromes. Erhardt LR Am J Cardiol; 1999 May; 83(10A):23G-25G. PubMed ID: 10482177 [TBL] [Abstract][Full Text] [Related]
20. A review of the GUARDIAN trial results: clinical implications and the significance of elevated perioperative CK-MB on 6-month survival. Chaitman BR J Card Surg; 2003; 18 Suppl 1():13-20. PubMed ID: 12691375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]